OptimizeRx Corp Announces Board and Executive Changes
Ticker: OPRX · Form: 8-K · Filed: Jan 10, 2025 · CIK: 1448431
| Field | Detail |
|---|---|
| Company | Optimizerx CORP (OPRX) |
| Form Type | 8-K |
| Filed Date | Jan 10, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $450,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation
TL;DR
OptimizeRx shakes up board & exec comp. New faces, new pay plans.
AI Summary
OptimizeRx Corp announced on January 3, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory plans for key executives. Specific details regarding the individuals involved and the financial implications of these changes are outlined within the report.
Why It Matters
Changes in a company's board and executive compensation can signal shifts in strategy, governance, or financial outlook, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate internal shifts that may affect company strategy and performance.
Key Players & Entities
- OptimizeRx Corp (company) — Registrant
- January 3, 2025 (date) — Date of Earliest Event Reported
- Nevada (jurisdiction) — State of incorporation
- 260 Charles Street, Suite 302, Waltham, MA 02453 (address) — Principal executive offices
FAQ
What specific roles have been affected by the departure of officers or directors?
The filing indicates the departure of certain officers and directors, but does not specify the exact roles affected in the provided text.
Who are the newly elected directors?
The filing mentions the election of new directors but does not name them in the provided text.
What are the key changes in the compensatory arrangements for officers?
The filing states there are updates to compensatory arrangements for certain officers, but the specific details of these changes are not provided in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on January 3, 2025.
What is OptimizeRx Corp's state of incorporation and principal executive office address?
OptimizeRx Corp is incorporated in Nevada and its principal executive offices are located at 260 Charles Street, Suite 302, Waltham, MA 02453.
Filing Stats: 823 words · 3 min read · ~3 pages · Grade level 12.5 · Accepted 2025-01-10 16:05:25
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 Par Value OPRX The Nasdaq Capital M
- $450,000 — o will receive: (1) continuation of his $450,000 per annum base salary for a period of e
Filing Documents
- ea0227345-8k_optimize.htm (8-K) — 26KB
- ea022734501ex10-1_optimize.htm (EX-10.1) — 75KB
- ex10-1_001.jpg (GRAPHIC) — 5KB
- 0001213900-25-002644.txt ( ) — 298KB
- oprx-20250103.xsd (EX-101.SCH) — 3KB
- oprx-20250103_lab.xml (EX-101.LAB) — 33KB
- oprx-20250103_pre.xml (EX-101.PRE) — 22KB
- ea0227345-8k_optimize_htm.xml (XML) — 4KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit Number Description 10.1 Separation and Advisory Agreement executed as of January 3, 2025 by and between the Company and William J. Febbo 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OPTIMIZERX CORPORATION Date: January 10, 2025 By: /s/ Marion Odence-Ford Name: Marion Odence-Ford Title: General Counsel 2